MPC — Marathon Petroleum Corporation

Sentiment is unambiguously bullish on momentum and analyst positioning as of 2026-09-13: MPC beat Q2 2026 consensus by a wide margin ($17.73 actual vs ~$12.31 expected, per the research brief), posted a 112% refining capture rate (up from 99% in Q1), and returned ~$2.8B via buybacks and dividends in the quarter versus $1.0B in Q1 2026. Piper Sandler hiked its target to $462 and UBS to $450, and the 33-analyst rating breakdown shows 26 Buy, 7 Hold, zero Sell. The counterweight is that the consensus average target ($355.78, recent average $352.64) actually sits BELOW the $395.93 price, and quantitative fair-value models cited in the brief land near $324 — so the tape is running ahead of the published estimates, which is a caution flag rather than a bearish signal by itself.

The three-year quarterly record is a textbook cyclical, and the direction changed violently in Q2 2026. Q3 2023 was a strong peak quarter (revenue $40.92B, operating income $4.75B, EPS $8.28), then 2024-2025 was a two-year trough: operating income fell to $0.81B in Q4 2024 and just $0.35B in Q1 2025, with Q1 2025 EPS of -$0.24. Full-year EPS ran $9.95 in 2024 and $13.36 in 2025 — margin compression, not growth. Then 2026 inflected hard: Q1 2026 was still weak (revenue $34.57B, operating income $1.40B, EPS $1.73), and Q2 2026 exploded to revenue $51.99B, gross profit $8.93B (17.2% gross margin vs 8.8% in Q2 2025), operating income $7.32B, and EPS $17.68 — the single largest operating-income quarter in the entire 12-quarter dataset, exceeding even Q3 2023's peak. Note the shape of this: it is a sharp inflected recovery off a genuine trough, but the magnitude of the latest quarter is driven by external crack-spread windfalls (Middle East disruption, tight global product flows) rather than by organic volume growth — revenue jumped ~50% quarter-over-quarter, which the deterministic score's own notes flag as possibly non-organic and distorting trend comparisons. Treat Q2 2026 as a windfall quarter, not a run-rate.

Expensive relative to its own history. As of 2026-09-13, MPC's TTM P/E was 13.63x versus a five-year average of 12.0x, and P/S was 0.751 versus a five-year average of 0.36 — more than double the historical sales multiple, which is the single loudest signal that the market has re-rated the stock. P/B of 6.04 looks alarming but is partly a mechanical artifact of aggressive buybacks (stockholders' equity fell from $24.42B at 2023-12-31 to $19.08B at 2026-06-30). The bull case rests entirely on the forward number: next-FY consensus EPS of $52.795 implies a forward P/E of only ~7.5x, which would be cheap for almost anything. The problem is that a 7.5x forward multiple on an all-time-high cyclical EPS estimate is the market explicitly saying it does not believe that estimate is durable. The deterministic score's own overlay agrees, labeling the stock 'Rich vs. its own history.' Net: cheap only if $50+ EPS is the new normal; expensive on every trailing and own-history measure.

This is now a 'priced-for-perfection on the windfall quarter' setup, not an 'underpricing a turnaround' setup. The stock is up 75.05% over six months and 50.21% over three months as of 2026-09-13, and it trades above both the consensus target ($355.78) and the recent-average target ($352.64) — when the price is above the average sell-side target, the easy money from estimate revisions has largely been made. The critical read is the gap between TTM EPS of $29.395 (13.6x) and next-FY consensus EPS of $52.795 (7.5x): the market is applying a peak-cycle multiple to peak-cycle earnings, which is the classic pattern when investors expect the forward number to be revised down. Watch the Q3 2026 print on 2026-11-02: if Q3 EPS holds anywhere near Q2's $17.68 the low forward multiple is validated and the stock can grind higher; if crack spreads normalize toward 2024-2025 levels, EPS reverts toward $10-15, the trailing multiple balloons, and the de-rating is fast and mechanical. Do not extrapolate the $17.68 quarter.

Extended and overbought as of 2026-09-13: RSI-14 stood at 74.41, with price 5.91% above the 20-day SMA, 18.89% above the 50-day SMA, and 61.12% above the 200-day SMA. The stock sat near the top of its 52-week range ($161.93-$409.11) and had just pulled back modestly from an all-time high near $402 to $395.93. Returns of +1.81% (1wk), +13.69% (1mo), +50.21% (3mo), and +75.05% (6mo) describe a near-parabolic advance, not a base. Being 61% above the 200-day in a commodity refining business is a mean-reversion warning, not a trend confirmation. Entry-timing implication: chasing here offers poor risk/reward; a pullback toward the 50-day (roughly the $330-335 area, which would also be near the consensus target) or an RSI reset below 50 would be a materially better entry for anyone initiating. Existing holders have a legitimate case for trimming into strength.

• Global refining crack spreads: structurally elevated by capacity rationalization and geopolitical supply disruption (including tightness around the Strait of Hormuz). This is the single largest determinant of MPC's earnings and is entirely outside management's control.
• Domestic feedstock advantage: MPC sources the vast majority of its crude from the U.S. and Canada, insulating it from international crude shocks and supporting the 112% capture rate reported in Q2 2026 (up from 99% in Q1).
• Refinery turnaround and maintenance cycle: planned and unplanned work across the system (including California assets) will temporarily reduce throughput while simultaneously keeping regional product inventories tight — a two-sided effect on earnings.
• Refined product demand tied to U.S. economic activity and global trade: a recession or demand destruction would compress crack spreads quickly, and refined-product demand faces a long-run structural headwind from electrification and efficiency.
• Capital-return sensitivity to rates and cash flow: MPC's buyback pace (~$2.8B returned in Q2 2026 vs $1.0B in Q1) is entirely FCF-dependent, and its 1.109% dividend yield competes poorly with short-duration fixed income if rates stay elevated.

• Q3 2026 earnings on 2026-11-02 — the key test of whether Q2's windfall crack spreads persisted, plus disclosure on turnaround impacts to throughput and the pace of further repurchases.
• Direction of global refining margins and any escalation or de-escalation of Middle East supply disruption — a sustained Hormuz-related supply shock extends the windfall; a normalization unwinds it quickly.
• Continued share repurchases and dividend growth off the ~$9.14B Q2 2026 free cash flow (operating cash flow $10.33B less capex $1.19B) — buybacks have already reduced share count from ~396M (Q3 2023) to ~291M (Q2 2026).
• MPLX midstream distribution growth and project execution, which provides a more stable earnings base under the refining cycle.
• Post-Q3 analyst target revisions — Piper Sandler sits at $462 and UBS at $450 versus Wells Fargo at $400; a round of downgrades to match the $355.78 consensus would be a negative catalyst.

• Crack spread normalization: Q2 2026's $7.32B operating income was a geopolitical windfall. Reversion toward 2024-2025 levels (full-year EPS of $9.95 in 2024 and $13.36 in 2025) would cut EPS by 50-70% from the current run-rate and force a sharp de-rating from 13.6x TTM.
• Valuation and technical extension: P/S of 0.751 versus a five-year average of 0.36, P/E of 13.63x versus a 12.0x five-year average, RSI of 74.41, and price 61.12% above the 200-day SMA as of 2026-09-13 — a lot of good news is already capitalized.
• Balance sheet leverage: long-term debt of $30.70B, debt-to-equity of 1.798, current ratio of 1.25, and a quick ratio of 0.887 leave less cushion if cash flow swings hard, which it does for refiners.
• Shrinking equity from buybacks: stockholders' equity fell from $24.42B (2023-12-31) to $19.08B (2026-06-30). The P/B of 6.04 is largely a mechanical artifact, but it also means the balance sheet absorbs cyclical downturns with less of a buffer.
• Data distortion undermining trend analysis: the +50% quarter-over-quarter revenue jump between 2026-03-31 and 2026-06-30 is flagged in the deterministic score's notes as possibly reflecting a non-organic event, which makes seasonality-adjusted growth metrics unreliable for forward modeling.

MPC is a well-run, genuinely cash-generative downstream operator, but as of 2026-09-13 the stock is priced as though the Q2 2026 windfall is the new normal rather than the top of a cyclical spike. At $395.93 the shares trade above the sell-side consensus target ($355.78), at 13.6x trailing earnings versus a 12.0x five-year average, more than double their historical P/S, and 61% above the 200-day moving average with RSI at 74 — that is a thin margin of safety in a commodity business whose earnings are set by crack spreads it does not control. The forward P/E of ~7.5x on a $52.80 EPS estimate is not a bargain signal; it is the market pricing in the expectation that estimate comes down. This is a name to own earlier in the cycle, not after a 75% six-month run into a peak-margin quarter. Not a short — the balance sheet is solid, buybacks are real, and a genuine Hormuz-driven supply shock could keep cracks elevated longer than anyone expects — but not a buy at this price either.

Three-method blend, weighted toward normalized earnings because MPC is a deep cyclical: (1) normalized mid-cycle EPS of ~$28 — roughly the 2022-2025 through-cycle average rebased for the post-buyback share count of ~291M — at a justified 11.5x mid-cycle refiner multiple = $322 (50% weight); (2) next-FY consensus EPS of $52.795 at a peak-earnings-tolerant 7.5x = $396 (30% weight); (3) normalized free cash flow of ~$6.5B (the 2024-2025 average, versus the $9.14B Q2 2026 windfall quarter) at a 6.5% required yield on ~290.6M shares = $344 (20% weight). Weighted result: 0.5($322) + 0.3($396) + 0.2($344) = $349, roughly 12% below the $395.93 price as of 2026-09-13 and close to the sell-side consensus target of $355.78.